Chai Discovery Secures $400M, Deploys with Pharma Giants.
Key takeaways
- Chai Discovery received $400 million in new funding.
- The company has deployed its technology with Eli Lilly, Pfizer, and Novartis.
- This signifies strong industry adoption of AI in drug discovery.
- The development points to a new era in medical innovation.
Who benefits
Summary
Chai Discovery has successfully deployed its technology with major pharmaceutical companies Eli Lilly, Pfizer, and Novartis, and has secured an additional $400 million in funding. This significant development positions the company at the forefront of medical innovation.
Why it matters
This news highlights significant investment and adoption of AI in drug discovery, signaling a shift in pharmaceutical R&D and potential for accelerated medical breakthroughs.
How to implement this in your domain
- 1Research Chai Discovery's specific technology and its applications in drug discovery.
- 2Identify potential partnership or investment opportunities in AI-driven biotech.
- 3Evaluate how similar AI approaches could be applied to R&D in other scientific fields.
- 4Stay informed on the progress of AI in pharmaceutical development for competitive insights.
Original post by @saranormous
"so proud of the amazing team @chaidiscovery! deployment with Eli Lilly, Pfizer and Novartis, and another $400M to build. we are standing in the foothills of the next era of medicine"
View on XOriginally posted by @saranormous on X · view source
Want to go deeper?
Turn these trends into skills with Learnijoy's hands-on AI & tech courses.
Explore coursesMore in AI News & Tools
EPA Proposes Rule Change Hiding Data Center Air Pollution Data
The US EPA is considering rescinding a rule that mandates public notice and comment periods for industrial air permits, which could allow data centers to build without local community input on potential pollution. This change would make it harder for residents to be informed about or influence the environmental impact of new data center construction.
Decathlon Boosts Demand Forecasting with Chronos-2 on AWS
Decathlon, a major sporting goods retailer, significantly improved its weekly demand forecasting accuracy by 11-15 points by deploying Chronos-2 on AWS. This implementation also reduced operational complexity and achieved very low inference costs on CPU-only instances.
Salesforce Achieves Multi-AZ HA with SageMaker Inference Components
Salesforce successfully used Amazon SageMaker AI Inference Component placement to distribute model copies across multiple Availability Zones, fulfilling their Multi-AZ high availability compliance needs. This approach maintained the cost efficiency of multi-model co-hosting while ensuring robust system resilience.